At Viatris, we empower people worldwide to live healthier at every stage of life

Learn More

Our Mission

At Viatris, we see healthcare not as it is, but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.

Viatris empowers people worldwide to live healthier at every stage of life.

We do so via:

Learn more
Access
Providing high quality, trusted medicines, regardless of geography or circumstance
Leadership
Advancing sustainable operations and innovative solutions to improve patient health
Partnership
Leveraging our collective expertise to connect people to products and services

Viatris is committed to setting new standards in healthcare in India

One of our global centers, two R&D centers, and several manufacturing facilities are located in India, where we produce high-quality oral solid doses, and injectable medicines for domestic and global markets. Scientific Affairs function in Viatris India includes portfolio management, R&D, regulatory affairs, product safety and risk management and clinical research teams.

Learn more about our impact
80 Billion+
Global Annual Dose Capacity
165+
Countries & Territories
~26
Manufacturing & Packaging Facilities Worldwide
Leadership
A New Kind of Healthcare Company
Learn more
COVID-19
Viatris India's Role in the Fight Against COVID-19
Learn more

Working At Viatris. Striving to help each employee realise their full potential.

Our strength comes from approximately 9,000 employees from various parts of India, providing us with a diverse mix of individuals committed to delivering on our mission to help people in living healthier lives. We are committed to transforming our workplaces where everyone is equally supported and empowered to reach their full potential.

Our Company

Our Leaders

We offer partners access through our global infrastructure

Our operating platform is designed to enable increased access to medicines and services across our industry.
Learn more

Our Products

A bold history and bright future

Learn how Mylan and Upjohn came together to form Viatris.
Learn more

Our Impact

Our key partners

Leveraging our collective expertise to connect people to products and services
Learn more

Mylan N.V. and Pfizer Inc concluded a global transaction combining Mylan N.V. and Upjohn (Pfizer’s off-patent branded and generic established medicines business) to create a new pharmaceutical company called Viatris Inc in 2020. Following the global transaction, Mylan Laboratories Limited and Mylan Pharmaceuticals Private Limited, the legal entities operating in India, became subsidiaries of Viatris Inc.

X